Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

Existe información en español para pacientes y cuidadores, para acceder, haga clic sobre “Select” al lado de “I am a U.S. Patient / Caregiver”.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

I am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional
SelectI am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional
I am a U.S. Patient / CaregiverNo, go back to the patient portal
SelectI am a U.S. Patient / CaregiverNo, go back to the patient portal
Non-US residents click here.

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

atropine sulfate injection, USP Principal Display Panel

PRINCIPAL DISPLAY PANEL - 10 mL Syringe Label

Atropine Sulfate 1 mg/10 mL (0.1 mg/mL)

10 mL Single-Dose Syringe

NDC 0409-1630-15
Rx only

Atropine Sulfate Injection, USP
1 mg/10 mL (0.1 mg/mL)

Hospira

For Intravenous, Intramuscular, Subcutaneous or Endotracheal use.

Distributed by Hospira, Inc., Lake Forest, IL 60045 USA

RL-7088

PRINCIPAL DISPLAY PANEL - 10 mL Syringe Label

PRINCIPAL DISPLAY PANEL - 10 mL Syringe Carton

NDC 0409-1630-15
Rx only

10 mL

Atropine
Sulfate
Injection, USP

1 mg/10 mL
(0.1 mg/mL)

For Intravenous,
Intramuscular,
Subcutaneous or
Endotracheal Use

Ansyr™

Single-Dose Syringe

Hospira

◀ PRESS AND PULL TO OPEN ▶

PRINCIPAL DISPLAY PANEL - 10 mL Syringe Carton

PRINCIPAL DISPLAY PANEL - 5 mL Syringe Label

Atropine Sulfate 0.25 mg/5 mL (0.05 mg/mL)

5 mL Single-Dose Syringe
Rx only
NDC 0409-9630-15

PEDIATRIC 0.25 mg/5 mL (0.05 mg/mL)
Atropine Sulfate Injection, USP

Hospira

For Intravenous, Intramuscular, Subcutaneous
or Endotracheal Use.

Dist. by Hospira, Inc.,
Lake Forest, IL
60045 USA

RL-7089

PRINCIPAL DISPLAY PANEL - 5 mL Syringe Label

PRINCIPAL DISPLAY PANEL - 5 mL Syringe Carton

NDC 0409-9630-15
Rx only

5 mL

Pediatric
Atropine
Sulfate
Injection, USP

0.25 mg/5 mL
(0.05 mg/mL)

For Intravenous,
Intramuscular,
Subcutaneous or
Endotracheal Use

Ansyr™

Single-Dose Syringe

Hospira

◀ PRESS AND PULL TO OPEN ▶

PRINCIPAL DISPLAY PANEL - 5 mL Syringe Carton

PRINCIPAL DISPLAY PANEL - 5 mL Syringe Label - 0409-4910

5 mL Single-dose syringe

NDC 0409-4910-11
Rx only

Atropine Sulfate Inj., USP
0.5 mg/5 mL (0.1 mg/mL)

For intravenous use.

Distributed by
Hospira, Inc., Lake Forest, IL 60045 USA

Hospira

RL-5314

PRINCIPAL DISPLAY PANEL - 5 mL Syringe Label - 0409-4910

PRINCIPAL DISPLAY PANEL - 5 mL Syringe Carton - 0409-4910

5 mL
NDC 0409-4910-11
Rx only

Atropine
Sulfate
Injection, USP
0.5 mg/5 mL
(0.1 mg/mL)

For intravenous use

with male luer lock
adapter and 20-Gauge
protected needle

Glass
LIFESHIELD™ ABBOJECT™
Unit of Use Syringe

Single-dose syringe
Discard unused portion

Hospira

◀ PRESS AND PULL TO OPEN

PRINCIPAL DISPLAY PANEL - 5 mL Syringe Carton - 0409-4910

PRINCIPAL DISPLAY PANEL - 10 mL Syringe Label - 0409-4911

10 mL Single-dose syringe

NDC 0409-4911-11
Rx only

Atropine Sulfate Inj., USP
1 mg/10 mL (0.1 mg/mL)

For intravenous use.

Distributed by
Hospira, Inc., Lake Forest, IL 60045 USA

Hospira

RL-5315

PRINCIPAL DISPLAY PANEL - 10 mL Syringe Label - 0409-4911

PRINCIPAL DISPLAY PANEL - 10 mL Syringe Carton - 0409-4911

10 mL
NDC 0409-4911-11
Rx only

Atropine
Sulfate
Injection, USP
1 mg/10 mL (0.1 mg/mL)

For intravenous use

with male luer lock
adapter and 20-Gauge
protected needle

Glass
LIFESHIELD™ ABBOJECT™
Unit of Use Syringe

Single-dose syringe.
Discard unused portion

Hospira

◀ PRESS AND PULL TO OPEN

PRINCIPAL DISPLAY PANEL - 10 mL Syringe Carton - 0409-4911
Show All Hide All
Show All Hide All
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Contact Medical Information.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event
Pfizer Safety

To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.

If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at
(800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatchor by calling
(800)-332-1088.